Inherited thrombophilia: Impact on human reproduction

被引:44
作者
Buchholz, T [1 ]
Thaler, CJ [1 ]
机构
[1] Univ Munich, LMU Hosp Grosshadern, Dept Obstet & Gynecol, Munich, Germany
关键词
fibrinolysis; hemostasis; placental perfusion; pregnancy;
D O I
10.1034/j.1600-0897.2003.00049.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of thrombotic disorders is a major threat for young women during pregnancy. It is one of the main causes of pregnancy-related disorders, which may also result in harm for the conceptus. Successful pregnancies require an even balance of coagulation and fibrinolysis, in order to secure stabilization of the basal plate as well as adequate placental perfusion. Thrombophilia is a laboratory definition for pre-disposing factors of thrombosis, which can be inherited or acquired. Many individuals, who carry a thrombotic defect remain asymptomatic, at least until additional boosting factors arise. The, documentation of thrombophilic causes of recurrent miscarriage or pregnancy-related disorders is important, because of availability of effective early treatment. There is a rapidly growing awareness on the relationship of genetic factors influencing hemostasis and pregnancy-related disorders. The aim of our review is to summarize this knowledge, focusing on common genetic variations.
引用
收藏
页码:20 / 32
页数:13
相关论文
共 107 条
  • [1] Adamek L, 1999, Pol Arch Med Wewn, V102, P1095
  • [2] Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A
    Akar, N
    Yilmaz, E
    Akar, E
    Avcu, F
    Yalçin, A
    Cin, S
    [J]. THROMBOSIS RESEARCH, 2000, 97 (04) : 227 - 230
  • [3] Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity
    Anwar, R
    Gallivan, L
    Edmonds, SD
    Markham, AF
    [J]. BLOOD, 1999, 93 (03) : 897 - 905
  • [4] Treatment of hereditary and acquired thrombophilic disorders
    Baker, WF
    Bick, RL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (04) : 387 - 406
  • [5] Factor V Leiden as a risk factor for miscarriage and reduced fertility
    Baré, SN
    Póka, R
    Balogh, I
    Ajzner, É
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2000, 40 (02) : 186 - 190
  • [6] beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study
    Behague, I
    Poirier, O
    Nicaud, V
    Evans, A
    Arveiler, D
    Luc, G
    Cambou, JP
    Scarabin, PY
    Bara, L
    Green, F
    Cambien, F
    [J]. CIRCULATION, 1996, 93 (03) : 440 - 449
  • [7] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [8] BERTINA RM, 1990, BLOOD, V76, P538
  • [9] Thrombophilia-associated pregnancy wastage
    Blumenfeld, Z
    Brenner, B
    [J]. FERTILITY AND STERILITY, 1999, 72 (05) : 765 - 774
  • [10] Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism?
    Bonnar, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (04) : 784 - 791